Glucose fuel cells that can effectively harness the body’s chemical energy and turn it into an electrical charge has been a long-term holy grail for scientists since such potential was first studied back in 1968.
But these biotech batteries have been challenged by an array of biocompatibility issues for almost as long.
Now, a team of researchers out of ETH Zurich have developed a novel fuel cell implant for the management of type 1 diabetes. What’s more, it connects to artificial beta cells designed by the same team in 2016 that can successfully produce and release insulin when triggered.
